PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026Cancer Research0 citations

Abstract 3361: Precise isolation of tumor-relevant EV sub-populations using the Kairos cLDEP particle sorter

View Full Paper
BSBoyang SuSXShujun XuRWReese Wunsche

Key Points

  • This research aims to develop a precise method for isolating tumor-relevant extracellular vesicle (EV) sub-populations from biofluids.
  • Utilized Kairos centripetal liquid dielectrophoretic (cLDEP) particle sorter for EV sorting.
  • Optimized operational protocols using polystyrene beads to establish sorting parameters.
  • Isolated EVs from prostate cancer patient plasma and cell culture conditioned media based on size and markers.
  • Conducted nucleic acid staining and immunolabeling for EV membrane and cancer-associated biomarkers.
  • Employed transmission electron microscopy for vesicle integrity verification.
  • Achieved 97% purity and 40% recovery of isolated EVs using the cLDEP sorter.
  • Sorted target EV sub-populations with 83.5-89.4% purity post-labeling and sorting.
  • Confirmed preserved vesicular integrity through microscopy.
  • Revealed molecular cargo consistent with EV identity and disease relevance in sorted sub-populations.

Abstract

Abstract Extracellular vesicles (EVs) are cell-derived fragments released by all cell types and are promising platforms for cancer detection and nanomedicine. Isolating and enriching ultra-pure EV sub-populations from patient biofluids based on cell- or cancer-specific biomarkers can reveal tumor-derived molecular signatures with diagnostic and therapeutic implications. However, most existing EV isolation methods rely on size and density, lacking specificity for defined EV subtypes. Existing nano flow cytometry (nFC) platforms (e.g., Astrios EQ) for EV sub-population sorting are also unsatisfactory due to lengthy preparation, limited specificity, and unknown recovery of target sub-populations. To overcome these limitations, we utilized the Apogee Kairos particle sorter, which applies centripetal liquid dielectrophoretic (cLDEP) force to redirect fluids around optically identified EVs, enabling high-speed, high-precision EV sub-population sorting. Operational protocols were optimized using polystyrene beads of defined sizes, achieving 97% purity and 40% recovery. EVs were isolated from cell culture conditioned media (CM) and prostate cancer patient plasma based on size (200-300 nm, 300-400 nm, 600-900 nm, 900 nm), and further sorted post nucleic acid staining, immunolabeling for EV membrane biomarkers (CD9, CD63, etc.) and cancer-associated biomarkers (PSMA, EpCAM, etc.), achieving 83.5-89.4% purity of target EV sub-populations. Transmission electron microscopy confirmed preserved EV vesicular integrity post-sorting. Protein and RNA analyses revealed the presence of molecular cargo in sorted sub-populations consistent with EV identity and disease relevance. We established a robust standard operating protocol (SOP) for the Kairos cLDEP sorter, providing a powerful approach for isolating cancer-derived EV sub-populations with high precision. This platform advances the utility of EV-based liquid biopsies by enabling tumor-selective EV capture for downstream molecular profiling. Citation Format: Boyang Su, Shujun Xu, Reese Wunsche, Dennis Lee, Hon Leong. Precise isolation of tumor-relevant EV sub-populations using the Kairos cLDEP particle sorter abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 3361.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Su et al. (2026) studied this question.

synapsesocial.com/papers/69d1fd3da79560c99a0a319chttps://doi.org/10.1158/1538-7445.am2026-3361
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 6523: High-purity isolation of tumor-derived extracellular vesicles via SEC-immunoaffinity integration improves diagnostic sensitivity in breast cancer2026
  2. 2Abstract 3340: Toward large-scale clinical implementation of extracellular vesicle profiling for precision oncology2026
  3. 3Abstract 6526: Integrated disc-fluidic platform for high-throughput extracellular vesicle processing in liquid biopsy2026
  4. 4Abstract 3362: Lipid nanoprobe magnetic beads enable high-purity plasma EV isolation for broad-spectrum cancer biomarker detection2026
  5. 5Refining Flow Cytometry-based Sorting of Plasma-derived Extracellular Vesicles2025 · 1 citations